Understanding the mechanism and role of cell membrane repair in Miyoshi Myopathy
了解细胞膜修复在三好肌病中的机制和作用
基本信息
- 批准号:10188422
- 负责人:
- 金额:$ 37.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-02 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntioxidantsB-LymphocytesCell SurvivalCell membraneCellsCholesterolCreatine KinaseCytoskeletonDYSF geneDevelopmentDiseaseEndosomesEnzymesExcisionExocytosisF-ActinGenerationsGenesHumanInjuryInterventionKnowledgeLimb-Girdle Muscular DystrophiesLipid BilayersLipidsLiverLysosomesMaintenanceMediatingMembraneMembrane FusionMembrane LipidsMembrane ProteinsMiyoshi myopathyMonitorMusMuscleMuscle CellsMuscle FibersMuscular DystrophiesMutationNormal CellOxidesPatientsPharmaceutical PreparationsProcessProteinsRecombinantsRoleSarcolemmaSerumSiteSkeletal MuscleSphingomyelinaseSphingomyelinsTestingTherapeuticTherapeutic InterventionVitamin EVitaminsacid sphingomyelinasecell injurycombinatorialdysferlinopathiesextracellularextracellular vesiclesimprovedin vivoinjuredinjury and repairinsightlive cell imagingmouse modelnovelnovel therapeuticsoxidationoxidized lipidpre-clinicalpreclinical efficacypreventrepaired
项目摘要
Summary
Many muscular dystrophies are caused by mutation in proteins that compromise the stability and integrity of
the muscle sarcolemma, which results in high serum level of muscle enzymes such as Creatine Kinase.
Understanding the mechanism by which healthy myofibers maintain their sarcolemmal integrity would enable
development of new therapies for these muscular dystrophies. Miyoshi myopathy (MM) and limb girdle
muscular dystrophy (LGMD) 2B, caused by mutations in dysferlin gene are such diseases. We have identified
that loss of sarcolemmal integrity in LGMD2B muscle fibers is due to the delay in fusion of lysosome with the
injured sarcolemma. This causes a delay in injury-triggered secretion of the lysosomal enzyme acid
sphingomyelinase. Providing extracellular sphingomyelinase reverses the repair deficit and offers a potential
therapy for LGMD2B. However, the mechanism by which alteration in sphingomyelin and other cell membrane
lipids facilitates repair of injured muscle cell membranes has not been fully elucidated. This proposal aims to
identify how lipids and lipid modifying enzymes such as acid sphingomyelinase facilitate maintenance of
sarcolemmal integrity and facilitate repair of injured sarcolemma. We will achieve this by visualizing and
modifying lipid composition of healthy muscle cell membrane and assess their effect on sarcolemmal integirty.
We will also assess how lipids respond are altered in the LGMD2B patient and mouse muscle cells to identify
potential therapeutic interventions to address these alterations. One such intervention we have established is
the use of acid sphingomyelinase and we will evaluate its preclinical therapeutic potential for LGMD2B. These
studies will not only help understand the role of lipids in maintenance of sarcolemmal integrity, but also provide
insight into developing novel therapies for muscular dystrophies that move beyond targeting the proteins to
also targeting the sarcolemmal lipids.
概括
许多肌肉营养不良是由蛋白质突变引起的,这些蛋白质会损害稳定性和完整性
肌肉肌膜出现,导致高血清肌肉水平的肌肉酶,例如肌酸激酶。
了解健康的肌纤维保持其肌肉完整性的机制将实现
开发这些肌肉营养不良的新疗法。 Miyoshi肌病(MM)和肢体腰带
由Dysferlin基因突变引起的肌肉营养不良(LGMD)2B是这种疾病。我们已经确定了
LGMD2B肌肉纤维中肌膜完整性的丧失是由于溶酶体融合的延迟
受伤的肌体育。这会导致溶酶体酶的损伤触发的分泌延迟
鞘磷脂酶。提供细胞外鞘磷脂酶可以逆转修复缺陷,并提供潜力
LGMD2B的治疗。但是,鞘磷脂和其他细胞膜改变的机制
脂质促进了受伤的肌肉细胞膜的修复,尚未完全阐明。该建议旨在
确定脂质和脂质修饰酶如何促进酸鞘磷脂酶促进维持
肌膜完整性并促进受伤的肌膜的修复。我们将通过可视化和
修饰健康肌肉细胞膜的脂质组成,并评估其对肌膜不动的作用。
我们还将评估LGMD2B患者和小鼠肌肉细胞的脂质反应如何改变
解决这些改变的潜在治疗干预措施。我们确定的一种这样的干预是
使用酸鞘磷脂酶,我们将评估其在LGMD2B的临床前治疗潜力。这些
研究不仅将有助于了解脂质在维持肌肉完整性中的作用,而且还提供
深入了解开发新型肌肉营养不良的新疗法,这些肌营养不良超出靶向蛋白质
还针对肌膜脂质。
项目成果
期刊论文数量(41)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mitochondrial dysfunction and consequences in calpain-3-deficient muscle.
- DOI:10.1186/s13395-020-00254-1
- 发表时间:2020-12-11
- 期刊:
- 影响因子:4.9
- 作者:Jahnke VE;Peterson JM;Van Der Meulen JH;Boehler J;Uaesoontrachoon K;Johnston HK;Defour A;Phadke A;Yu Q;Jaiswal JK;Nagaraju K
- 通讯作者:Nagaraju K
Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis.
- DOI:10.1126/sciadv.add9984
- 发表时间:2023-07-07
- 期刊:
- 影响因子:13.6
- 作者:
- 通讯作者:
The macrophage as a Trojan horse for antisense oligonucleotide delivery.
巨噬细胞作为反义寡核苷酸递送的特洛伊木马。
- DOI:10.1080/14728222.2018.1482279
- 发表时间:2018-06
- 期刊:
- 影响因子:5.8
- 作者:Novak JS;Jaiswal JK;Partridge TA
- 通讯作者:Partridge TA
S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells.
- DOI:10.1038/ncomms4795
- 发表时间:2014-05-08
- 期刊:
- 影响因子:16.6
- 作者:Jaiswal, Jyoti K.;Lauritzen, Stine P.;Scheffer, Luana;Sakaguchi, Masakiyo;Bunkenborg, Jakob;Simon, Sanford M.;Kallunki, Tuula;Jaattela, Marja;Nylandsted, Jesper
- 通讯作者:Nylandsted, Jesper
Early Endosomes Undergo Calcium-Triggered Exocytosis and Enable Repair of Diffuse and Focal Plasma Membrane Injury.
- DOI:10.1002/advs.202300245
- 发表时间:2023-11
- 期刊:
- 影响因子:15.1
- 作者:Bittel, Daniel C.;Jaiswal, Jyoti K.
- 通讯作者:Jaiswal, Jyoti K.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JYOTI K JAISWAL其他文献
JYOTI K JAISWAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JYOTI K JAISWAL', 18)}}的其他基金
Molecular mechanism of dysregulated airway antiviral responses in children with Trisomy 21
21三体症儿童气道抗病毒反应失调的分子机制
- 批准号:
10296156 - 财政年份:2021
- 资助金额:
$ 37.11万 - 项目类别:
IFN responses and SARS-CoV-2 Receptor ACE2 Expression in the airway epithelium of young children with Down Syndrome
唐氏综合症幼儿气道上皮中的 IFN 反应和 SARS-CoV-2 受体 ACE2 表达
- 批准号:
10215714 - 财政年份:2020
- 资助金额:
$ 37.11万 - 项目类别:
Genetics and Genomics of Muscle Postdoctoral Training Program
肌肉遗传学与基因组学博士后培养项目
- 批准号:
9272835 - 财政年份:2010
- 资助金额:
$ 37.11万 - 项目类别:
Understanding the mechanism and role of cell membrane repair in Miyoshi Myopathy
了解细胞膜修复在三好肌病中的机制和作用
- 批准号:
8089483 - 财政年份:2008
- 资助金额:
$ 37.11万 - 项目类别:
Understanding the mechanism and role of cell membrane repair in Miyoshi Myopathy
了解细胞膜修复在三好肌病中的机制和作用
- 批准号:
8269083 - 财政年份:2008
- 资助金额:
$ 37.11万 - 项目类别:
Understanding the mechanism and role of cell membrane repair in Miyoshi Myopathy
了解细胞膜修复在三好肌病中的机制和作用
- 批准号:
7650143 - 财政年份:2008
- 资助金额:
$ 37.11万 - 项目类别:
Understanding the mechanism and role of cell membrane repair in Miyoshi Myopathy
了解细胞膜修复在三好肌病中的机制和作用
- 批准号:
9534519 - 财政年份:2008
- 资助金额:
$ 37.11万 - 项目类别:
相似国自然基金
抗氧化剂/活性离子时序释放复合支架构建及其修复糖尿病骨缺损的机制研究
- 批准号:32360232
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
塑料抗氧化剂内分泌干扰转化产物的识别与环境行为研究
- 批准号:22306042
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
农用地膜抗氧化剂的土壤污染特征及其微生物效应与机制研究
- 批准号:42377223
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
自然水体轮胎抗氧化剂高毒醌类衍生物非靶向识别及生物转化机制
- 批准号:42377360
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
取代对苯二胺抗氧化剂及其醌衍生物的人体内暴露标志物研究
- 批准号:22306031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Transcriptional Activation of p62 by the master antioxidant NRF2 in EBV latency
EBV潜伏期主要抗氧化剂NRF2对p62的转录激活
- 批准号:
10726975 - 财政年份:2023
- 资助金额:
$ 37.11万 - 项目类别:
Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils
肿瘤浸润中性粒细胞的免疫抑制和代谢重组
- 批准号:
10637160 - 财政年份:2023
- 资助金额:
$ 37.11万 - 项目类别:
Oxidized lipids and microvesicle particles as effectors for chemical threats to skin
氧化脂质和微泡颗粒作为皮肤化学威胁的效应器
- 批准号:
10648739 - 财政年份:2023
- 资助金额:
$ 37.11万 - 项目类别:
Islet encapsulation to elicit localized immunosuppression and immune modulation following transplantation
移植后胰岛封装引发局部免疫抑制和免疫调节
- 批准号:
10667778 - 财政年份:2023
- 资助金额:
$ 37.11万 - 项目类别:
Mechanisms of augmented UVB immunosuppressive responses by polyaromatic hydrocarbons
多环芳烃增强 UVB 免疫抑制反应的机制
- 批准号:
10688121 - 财政年份:2022
- 资助金额:
$ 37.11万 - 项目类别: